In addition to the tumor staging system, serum markers such as carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) have been proved as independent risk factors in predicting the prognosis of ICC patients (15). This evidence concerns the gene CEACAM5 and intrahepatic cholangiocarcinoma.